Year 2020 / Volume 112 / Number 3
Original
Gastric per-oral endoscopic myotomy (G-POEM) is a promising treatment for refractory gastroparesis: a systematic review and meta-analysis

219-228

DOI: 10.17235/reed.2020.6559/2019

Jin Yan, Yuyong Tan, Bingyi Zhou, Shilan Zhang, Xuehong Wang, Deliang Liu,

Abstract
Aim: to evaluate the efficacy and safety of gastric per-oral endoscopic myotomy (G-POEM) for the treatment of refractory gastroparesis. Methods: PubMed, Embase and Cochrane databases were searched and used for study inclusion. Clinical studies since January 2013 to October 2019 were identified as suitable for inclusion. Conference papers, review articles, case reports, animal studies, letters, studies with repetitive data, studies that did not mention the Gastroparesis Cardinal Symptom Index (GCSI) score/gastric emptying scintigraphy (GES) hours or were not indicated in the standard form were excluded. GCSI score, GCSI reduction, gastric emptying scintigraphy at four hours (GES-4h) and GES time (GET) reduction were considered as major indexes and the meta-analysis was achieved using Review Manager 5.3. Research bias was measured according to Cochrane handbook. Results: nine studies were included with a total of 235 patients that underwent G-POEM, and the technical success rate was 100%. After G-POEM, patients reported changes in GCSI score (6/9 studies, mean difference 1.41 [CI: 0.93, 1.88], p < 0.0001), GCSI reduction (8/9 studies, odds ratio 3.00 [CI: 2.24, 4.03], p < 0.0001), GES-4h (8/9 studies, mean difference 23.78 [CI: 19.88, 27.68], p < 0.00001) and GET reduction (6/9 studies, odds ratio 3.50 [CI: 2.12, 5.78], p < 0.00001). The intra-procedure complication rate was 5.1% (12/235), including capnoperitoneum (seven cases) and accidental mucotomy (five cases). The post-procedure complication rate was 6.8% (16/235), including abdominal pain (three cases), bleeding (three cases), ulcer (one case), difficulty swallowing (one case) and others (eight cases). Both per- and post-procedure complications were easily managed by conservative or endoscopic treatments. Conclusion: the results show that gastroparesis patients can benefit from G-POEM, the success rate was impressive and the complication rate was relatively low. However, caution is necessary when interpreting the results, primarily due to the limitations of uncontrolled studies. Randomized control studies are still needed for further evaluations.
Share Button
New comment
Comments
No comments for this article
References
[1] Camilleri M, Parkman HP, Shafi MA, et al. Clinical guideline: Management of gastroparesis[J]. Am J Gastroenterol, 2013, 108(1):18-37.
[2] Oh JH, Pasricha PJ. Recent advances in the pathophysiology and treatment of gastroparesis[J]. J Neurogastroenterol Motil, 2013, 19(1):18-24.
[3] Grover M, Bernard CE, Pasricha PJ, et al. Clinical-histological associations in gastroparesis: Results from the gastroparesis clinical research consortium[J]. Neurogastroenterol Motil, 2012, 24(6):531-539, e249.
[4] Groneberg D, Voussen B, Friebe A. Integrative control of gastrointestinal motility by nitric oxide[J]. Curr Med Chem, 2016, 23(24):2715-2735.
[5] Parkman HP, Hasler WL, Fisher RS. American gastroenterological association technical review on the diagnosis and treatment of gastroparesis[J]. Gastroenterology, 2004, 127(5):1592-1622.
[6] Kawai M, Peretta S, Burckhardt O, et al. Endoscopic pyloromyotomy: A new concept of minimally invasive surgery for pyloric stenosis[J]. Endoscopy, 2012, 44(2):169-173.
[7] Khashab MA, Stein E, Clarke JO, et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: First human endoscopic pyloromyotomy (with video)[J]. Gastrointest Endosc, 2013, 78(5):764-768.
[8] Revicki DA, Rentz AM, Dubois D, et al. Gastroparesis cardinal symptom index (gcsi): Development and validation of a patient reported assessment of severity of gastroparesis symptoms[J]. Qual Life Res, 2004, 13(4):833-844.
[9] Khashab MA, Ngamruengphong S, Carr-Locke D, et al. Gastric per-oral endoscopic myotomy for refractory gastroparesis: Results from the first multicenter study on endoscopic pyloromyotomy (with video)[J]. Gastrointest Endosc, 2017, 85(1):123-128.
[10] Shlomovitz E, Pescarus R, Cassera MA, et al. Early human experience with per-oral endoscopic pyloromyotomy (pop)[J]. Surg Endosc, 2015, 29(3):543-551.
[11] Landreneau JP, Strong AT, El-Hayek K, et al. Laparoscopic pyloroplasty versus endoscopic per-oral pyloromyotomy for the treatment of gastroparesis[J]. Surg Endosc, 2018,
[12] Levinthal DJ, Bielefeldt K. Systematic review and meta-analysis: Gastric electrical stimulation for gastroparesis[J]. Auton Neurosci, 2017, 202:45-55.
[13] Friedenberg FK, Palit A, Parkman HP, et al. Botulinum toxin a for the treatment of delayed gastric emptying[J]. Am J Gastroenterol, 2008, 103(2):416-423.
[14] Miller LS, Szych GA, Kantor SB, et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle[J]. Am J Gastroenterol, 2002, 97(7):1653-1660.
[15] Costanzo CM, Vinocur C, Berman L. Postoperative outcomes of open versus laparoscopic pyloromyotomy for hypertrophic pyloric stenosis[J]. J Surg Res, 2018, 224:240-244.
[16] Shada AL, Dunst CM, Pescarus R, et al. Laparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesis[J]. Surg Endosc, 2016, 30(4):1326-1332.
[17] Landreneau JP, Strong AT, El-Hayek K, et al. Laparoscopic pyloroplasty versus endoscopic per-oral pyloromyotomy for the treatment of gastroparesis[J]. Surg Endosc, 2019, 33(3):773-781.
[18] Xue HB, Fan HZ, Meng XM, et al. Fluoroscopy-guided gastric peroral endoscopic pyloromyotomy (g-poem): A more reliable and efficient method for treatment of refractory gastroparesis[J]. Surg Endosc, 2017, 31(11):4617-4624.
[19] Khashab MA, Kumbhari V, Azola A, et al. Intraoperative determination of the adequacy of myotomy length during peroral endoscopic myotomy (poem): The double-endoscope transillumination for extent confirmation technique (detect)[J]. Endoscopy, 2015, 47(10):925-928.
[20] Khoury T, Mizrahi M, Mahamid M, et al. State of the art review with literature summary on gastric peroral endoscopic pyloromyotomy for gastroparesis[J]. J Gastroenterol Hepatol, 2018,
[21] Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity[J]. Gastroenterology, 2011, 140(1):101-115.
[22] Gangula PR, Sekhar KR, Mukhopadhyay S. Gender bias in gastroparesis: Is nitric oxide the answer?[J]. Dig Dis Sci, 2011, 56(9):2520-2527.
[23] Rao JN. Estrogens and gastroparesis: A clinical relevance[J]. Dig Dis Sci, 2013, 58(6):1449-1451.
[24] Gonzalez JM, Benezech A, Vitton V, et al. G-poem with antro-pyloromyotomy for the treatment of refractory gastroparesis: Mid-term follow-up and factors predicting outcome[J]. Aliment Pharmacol Ther, 2017, 46(3):364-370.
[25] Rodriguez JH, Haskins IN, Strong AT, et al. Per oral endoscopic pyloromyotomy for refractory gastroparesis: Initial results from a single institution[J]. Surgical Endoscopy and Other Interventional Techniques, 2017:1-8.
[26] Malik Z, Kataria R, Modayil R, et al. Gastric per oral endoscopic myotomy (g-poem) for the treatment of refractory gastroparesis: Early experience[J]. Dig Dis Sci, 2018,
[27] Rodriguez J, Strong AT, Haskins IN, et al. Per-oral pyloromyotomy (pop) for medically refractory gastroparesis: Short term results from the first 100 patients at a high volume center[J]. Ann Surg, 2018, 268(3):421-430.
[28] Mekaroonkamol P, Dacha S, Wang L, et al. Gastric peroral endoscopic pyloromyotomy reduces symptoms, increases quality of life, and reduces health care use for patients with gastroparesis[J]. Clin Gastroenterol Hepatol, 2018,
[29] Xu J, Chen T, Elkholy S. Gastric peroral endoscopic myotomy (g-poem) as a treatment for refractory gastroparesis: Long-term outcomes[J]. 2018, 2018:6409698.
Related articles

Letter

Digestive involvement in a patient with Lambert-Eaton syndrome

DOI: 10.17235/reed.2020.6846/2019

Citation tools
Yan J, Tan Y, Zhou B, Zhang S, Wang X, Liu D, et all. Gastric per-oral endoscopic myotomy (G-POEM) is a promising treatment for refractory gastroparesis: a systematic review and meta-analysis. 6559/2019


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1775 visits.
This article has been downloaded 377 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 10/08/2019

Accepted: 27/11/2019

Online First: 21/02/2020

Published: 05/03/2020

Article revision time: 93 days

Article Online First time: 195 days

Article editing time: 208 days


Share
This article has been rated by 2 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology